Who has invested in Kazia Therapeutics?

Willoughby Capital, Quest Asset Partners, Platinum Asset Managers are named among the investors backing Kazia Therapeutics.

Kazia Therapeutics Funding: $5.4M Raised, Series A (2019)

Kazia Therapeutics funding overview

Kazia Therapeutics is based in Sydney, Australia. Kazia Therapeutics has raised $5.4M in total disclosed funding. That places its disclosed total in the $1M–$25M range. Its most recent disclosed round is a Series A announced in December 2019. The round record for Kazia Therapeutics runs through 2019; nothing later has been disclosed. Investors on record include Willoughby Capital, Quest Asset Partners, Platinum Asset Managers. 3 distinct backers are named across the disclosed rounds.

Kazia Therapeutics at a glance

Total raised: $5.4M
Latest round: Series A
Latest round date: December 2019
Headquarters: Sydney, Australia
Notable investors: Willoughby Capital, Quest Asset Partners, Platinum Asset Managers

Frequently asked about Kazia Therapeutics funding

How much has Kazia Therapeutics raised?: Kazia Therapeutics has raised $5.4M in total disclosed funding across the rounds on record.
Who has invested in Kazia Therapeutics?: Willoughby Capital, Quest Asset Partners, Platinum Asset Managers are named among the investors backing Kazia Therapeutics.
What was the latest Kazia Therapeutics funding round?: The most recent disclosed round is a Series A, announced in December 2019.
Where is Kazia Therapeutics based?: Kazia Therapeutics is based in Sydney, Australia.
When did Kazia Therapeutics last raise?: The last disclosed Kazia Therapeutics round closed in December 2019 at Series A.

Kazia Therapeutics totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Sydney below to benchmark round size and investor mix.

Kazia Therapeutics Funding: $5.4M Raised, Series A (2019)

Kazia Therapeutics funding overview

Kazia Therapeutics at a glance

Frequently asked about Kazia Therapeutics funding

Companies related to Kazia Therapeutics (22)

Browse related funding lists (3)